Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
1.780
+0.140 (8.54%)
At close: Nov 21, 2024, 4:00 PM
1.870
+0.090 (5.06%)
After-hours: Nov 21, 2024, 7:43 PM EST

Werewolf Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-62.12-37.37-53.81-49.98-15.04-10.25
Depreciation & Amortization
1.831.761.10.220.150.03
Other Amortization
-0.060.2---
Loss (Gain) From Sale of Assets
--0.01---
Stock-Based Compensation
8.798.017.44.10.630.56
Other Operating Activities
0.870.821.960.52-6.670.83
Change in Accounts Receivable
5.455.58-6.93---
Change in Accounts Payable
1.82-4.343.051.010.390.12
Change in Unearned Revenue
-2.4-6.327.66---
Change in Other Net Operating Assets
-0.76-0.82-1.241.271.92-0.83
Operating Cash Flow
-46.52-32.61-40.6-42.88-18.62-9.54
Capital Expenditures
-0.33-0.77-3.61-0.5-0.56-0.27
Investing Cash Flow
-0.33-0.77-3.61-0.5-0.56-0.27
Long-Term Debt Issued
-40----
Net Debt Issued (Repaid)
-1040----
Issuance of Common Stock
30.2818.4315.99111.810.030
Other Financing Activities
-0.67--0.09-2.38-0.34-0.19
Financing Cash Flow
19.6158.4315.91109.4393.8621.91
Net Cash Flow
-27.2425.05-28.366.0574.6712.1
Free Cash Flow
-46.85-33.38-44.21-43.37-19.18-9.81
Free Cash Flow Margin
-1383.64%-167.38%-269.54%---
Free Cash Flow Per Share
-1.13-0.94-1.53-2.35-19.09-15.35
Cash Interest Paid
3.492.56----
Levered Free Cash Flow
-27.67-22.16-26.18-24.49-10.8-
Unlevered Free Cash Flow
-24.92-20.26-26.39-24.49-10.8-
Change in Net Working Capital
-6.173.94-3.76-3-2.98-
Source: S&P Capital IQ. Standard template. Financial Sources.